Nephrology Doctors in Bethlehem, PA Accepting Medicare

5 Nephrology doctors found. Showing 1 - 5

Robert N Pursell, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 701 Ostrum St, Suite 602, Bethlehem, PA 18015 Phone: 610-865-5888    Fax: 610-865-1697

Joseph M Jacobs, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 701 Ostrum St, Suite 602, Bethlehem, PA 18015 Phone: 610-865-5888    Fax: 610-865-1697

Michael Anthony Dunn, D.O. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 701 Ostrum St, Suite 602, Bethlehem, PA 18015 Phone: 610-865-5888    Fax: 610-252-8431

Adam D Dratch, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 701 Ostrum St, Suite 602, Bethlehem, PA 18015 Phone: 610-865-5888    Fax: 610-865-1697

Richard W Snyder, DO Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 701 Ostrum St, Suite 602, Bethlehem, PA 18015 Phone: 610-865-5888    Fax: 610-865-1697

News Archive

CytRx initiates Phase 3 clinical trial to evaluate efficacy of aldoxorubicin in STS patients

CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has initiated a pivotal global Phase 3 clinical trial to evaluate the efficacy and safety of aldoxorubicin as a second-line treatment for patients with soft tissue sarcoma (STS) under a Special Protocol Assessment with the FDA.

Robotically assisted minimally invasive bladder reconstructive surgery on children performed

For the first time, a surgical robot has been used to perform minimally invasive reconstructive surgery on five children whose bladder was dysfunctional because they were born with spina bifida [incomplete formation of the spine or spinal cord].

Oncolytic virotherapy medicine shows positive treatment outcomes in late-stage cancer patients

The surprisingly positive treatment outcomes using Rigvir virotherapy for late stages cancer patients were recently published.

CytRx announces its plans to advance multiple oncology development programs in 2010

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced its plans for 2010 aimed at advancing the clinical development of its high-value drug development pipeline and enhancing shareholder value.

Research sheds light on pathways involved in transmitting itch sensations from skin to brain

Researchers from North Carolina State University have pinpointed a particular neuropeptide associated with transmitting itch signals in mice with atopic dermatitis.

Read more Medical News

› Verified 3 days ago